In an op-ed featured in the February issue of Nature Medicine, MJFF’s CEO Todd Sherer, PhD, urges his peers in drug development to embrace the power of collaboration. Much work remains to bridge the high-risk and multi-billion dollar gap from discovery to the clinic, but the Foundation has seen firsthand how efforts that emphasize collaboration over competition can help speed promising treatments toward patients. Todd writes:

“…collaborations among academic and industry players are ignited when researchers share information in real time… meeting scientists’ needs for better research tools enables them to move toward breakthroughs faster… investing in early promising therapeutic targets is crucial. Despite the inherent risks involved in these efforts, the reward could be the cure that countless patients don’t have time to wait for.”

The full op-ed is now available in the current issue of Nature Medicine and online.